4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ocugen, Inc. (OCGN) operates in the Biotechnology industry and is headquartered in Malvern, United States with about 116 employees. Its market capitalization is roughly $450 million. In the fiscal year ended 2025-12-31, OCGN reported $4M in revenue and ($68M) in net income.
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health.
Interactive charts & full statements → Open the OCGN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $4M | $4M | $6M | $2M | — |
| Operating Income (EBIT) | ($63M) | ($55M) | ($66M) | ($89M) | — |
| Net Income | ($68M) | ($54M) | ($63M) | ($87M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | ($0M) | $2M | $1M | $2M |
| Operating Income (EBIT) | ($18M) | ($17M) | ($18M) | ($14M) | ($14M) |
| Net Income | ($19M) | ($18M) | ($20M) | ($15M) | ($15M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $44M | $82M | $64M | $109M | — |
| Total Liabilities | $56M | $53M | $24M | $35M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OCGN viewer.
About TickerBase · Data methodology & sources